Structure |
Chemical Name |
CAS |
MF |
|
4-Hydroxy AtoMoxetine Oxalate |
457634-21-8 |
C19H23NO6 |
|
1-エチル-4-オキソ-6-クロロ-7-(1-ピペラジニル)-1,4-ジヒドロ-3-キノリンカルボン酸 |
67681-84-9 |
C16H18ClN3O3 |
|
Desfluoro flurbiprofen axetil |
1685278-08-3 |
C19H20O4 |
|
Desloratadine IMpurity 6 |
38092-90-9 |
C20H21ClN2 |
|
ErtapeneM Ring Open IMpurity |
|
|
|
LincoMycin iMpurity C |
|
|
|
Norfloxacin iMpurity E |
|
|
|
Posaconazole iMpurity 2 |
|
|
|
Quetiapine IMpurity [2-(2-Piperazin-1-yl)ethoxy)ethanol] |
2206135-50-2 |
C25H18N2S2 |
|
Rabeprazole iMpurity (Chloro interMediate) |
|
|
|
TaMsulosin IMpurity F |
|
C20H28N2O5S |
|
TiaMulin IMpurity E (TiaMulone,11-Oxo TiaMulin) |
113323-39-0 |
C28H45NO4S |
|
2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol |
848814-27-7 |
C21H27N3O3S |
|
(3AR,7R,7AR)-2,2-ジエチル-3A,6,7,7A-テトラヒドロ-7-[(メチルスルホニル)オキシ]-1,3-ベンゾジオキソール-5-カルボン酸エチルエステル |
204254-90-0 |
C15H24O7S |
|
TorseMide Carboxylic Acid |
113844-99-8 |
C16H18N4O5S |
|
(6-BroMo-2-ethyl-3-benzofuranyl)(3,5-dibroMo-4-hydroxyphenyl)Methanone |
1402819-05-9 |
C17H11Br3O3 |
|
5'-broMo-[2,3'-bipyridin]-6'(1'H)-one |
381233-79-0 |
C10H7BrN2O |
|
1-((2R,3R)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one |
2243786-01-6 |
C30H35N5O3 |
|
DEXTROMETHORPHAN N-OXIDE |
1177494-18-6 |
C18H25NO2 |
|
1-[(2-CHLOROPHENYL)DIPHENYLMETHYL]-1H-PYRAZOLE |
|
C22H17ClN2 |
|
Celecoxib Impurity 2 |
948293-46-7 |
C11H9F3N2 |
|
1-METHYL-4-PHENYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-AMINE |
63156-74-1 |
C11H10F3N3 |
|
2-(3-メトキシフェノキシ)エタンアミン |
6487-86-1 |
C9H13NO2 |
|
Sugammadex sodium Impurity 45 |
|
|
|
Carboprost Trometamol 1 |
|
|
|
Tenofovir Impurity 113 |
1335287-28-9 |
C11H13IN4O |
|
Cefazolin USP Impurity L-δ3 |
|
|
|
Cabozantinib impurity 38 |
|
|
|
Cabozantinib impurity 57 |
|
|
|
(2R,3S)-3-(6-(1-(6-chloro-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol hydrochloride |
|
|
|
(R)-2-((2R,5R)-3,6-dioxo-5-phenylpiperazin-2-yl)-5-methyl-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
860011-30-9 |
C16H17N3O4S |
|
Dapoxetine impurity 54 |
|
|
|
Doxofylline Impurity 21 |
|
|
|
Dapoxetine impurity 60 |
|
|
|
Bosutinib Impurity 37 |
2095306-27-5 |
C39H30Cl4N6O6 |
|
1-メチル-3-ヒドロキシインドリン-5,6-ジオン |
54-06-8 |
C9H9NO3 |
|
5-(3-fluorophenyl)-1H-pyrrole-3-carbaldehyde |
|
C11H8FNO |
|
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid bis(1-methylethyl) ester |
21881-78-7 |
C21H26N2O6 |
|
4-メチルベンゼンスルホン酸2-ヒドロキシエチル |
42772-85-0 |
C9H12O4S |
|
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- |
1564265-94-6 |
C18H25N3O2 |
|
EMpagliflozin iMpurity 8 |
|
|
|
EMpagliflozin iMpurity 13 |
2125472-55-9 |
C23H25ClO8 |
|
6-Methyldi(ondansetron-3-de(1,2-diMethyl-1H-iMidazole)) |
1365727-07-6 |
C27H26N2O2 |
|
Budesonide Impurity (1, 4-Androstadien-11-beta-16-alfa-diol-3, 17-dione) |
910299-74-0 |
C19H24O4 |
|
Etoricoxib Impurity 12 |
646459-41-8 |
C21H16ClN3O2S |
|
Levofloxacin Tetrafluoro Impurity 2 |
103995-33-1 |
C14H12F4O4 |
|
Mupirocin Impurity C |
|
C26H44O9 |
|
2-(3,4-ジメトキシフェニル)-2-エチル-5-[メチル[2-(3,4-ジメトキシフェニル)エチル]アミノ]-ペンタンニトリル |
67018-83-1 |
C26H36N2O4 |
|
Warfarin Impurity 1 |
55901-61-6 |
C13H14O |
|
Macitentan impurity B |
441796-13-0 |
C18H18Br2N6O4S |
|
Meropenem IMP B |
|
|
|
4-(6-ブロモピリジン-3-イル)ピペラジン-1-カルボン酸TERT-ブチル |
412348-27-7 |
C14H20BrN3O2 |
|
(2R,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-56-8 |
C23H29NO4 |
|
Linagliptin Impurity D |
666816-91-7 |
C20H28N6O4 |
|
テルミサルタン-D3 |
1189889-44-8 |
C33H27D3N4O2 |
|
3-クロロ-4-モルホリノ-1,2,5-チアジアゾール |
30165-96-9 |
C6H8ClN3OS |
|
Atomoxetine impurity D CRS |
873310-29-3 |
C17H21NO |
|
Beraprost Impurity 2 |
|
|
|
Brivudine Impurity 2 |
|
|
|
N-(4-メチルピリジン-3-イル)カルバミン酸メチル |
694495-63-1 |
C8H10N2O2 |
|
4-chloro-6-(1-(6-ethyl-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidine |
|
|
|
Empagliflozin Impurity 74 |
|
|
|
Empagliflozin Impurity 78 |
|
|
|
Empagliflozin Impurity 85 |
|
|
|
Relugolix Impurity 11 |
|
|
|
(8S,16S,Z)-16-amino-5-(2-aminothiazol-4-yl)-11-imino-2,2-dimethyl-6,9-dioxo-8-((S)-1-(sulfoamino)ethyl)-3-oxa-4,7,10,12-tetraazaheptadec-4-ene-1,17-dioic acid |
|
|
|
1-(3,4-bis(hydroxymethyl)-1H-pyrrol-2-yl)ethan-1-one |
|
|
|
Gadobutrol Impurity 32 |
|
C14H23GdN4O6 |
|
Ornidazole Impurity 23 |
1100750-18-2 |
|
|
Olanzapine impurity CNB |
|
|
|
Pitavastatin Impurity 74 |
167934-30-7 |
C29H30FNO4 |
|
Etoricoxib Impurity 35 |
855307-79-8 |
C18H13ClN2O2S |
|
Febuxostat Impurity 102 |
|
|
|
Ticagrelor Impurity 131 |
|
|
|
door bird impurities |
|
|
|
Topiroxostat Impurity 41 |
|
|
|
1-((2R,3R)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-((methyl(3-((2-(methylamino)acetoxy)methyl)pyridin-1-oxide-2-yl)carbamoyl)oxy)ethyl)-1H-1,2,4-triazol-4-ium |
|
|
|
2-Piperidinecarboxylic acid, 1-formyl-, (1S,2R,3S,6R,7E,10S,12S)-3-hydroxy-1-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-12-methoxy-2,8,10-trimethyl-5-oxo-6-(2-propen-1-yl)-12-[(2R,3S,5R)-tetrahydro-3-methoxy-5-methyl-6-oxo-2H-pyra |
143210-33-7 |
C43H69NO11 |
|
Blonanserin Impurity 15 |
143213-96-1 |
C17H17ClFNO |
|
1H-Pyrazole-1-propanoic acid, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (βR)- |
2102675-40-9 |
C17H19N5O2 |
|
sodium ((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d] pyrimidin-5-yl)ethyl)benzamido)-4-carboxylatobutanoyl)-L-glutamate |
|
|
|
1H-Purin-2-amine, 6,9-dihydro-9-[(1S,3R,4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-6-(phenylmethoxy)-N-(triphenylmethyl)- |
2097265-84-2 |
C52H49N5O3 |
|
6,6'-oxybis(3-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile) |
|
|
|
Glycine, N-[(1-ethyl-4-hydroxy-7-phenoxy-3-isoquinolinyl)carbonyl]- |
808120-20-9 |
C20H18N2O5 |
|
Vonoprazan Impurity 55 |
|
|
|
N-(5-((diphenylphosphoryl)methyl)-4-(2-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide |
|
|
|
Ethane, 1,1,1-trichloro-2,2,2-trimethoxy- |
19932-79-7 |
C5H9Cl3O3 |
|
Budesonide Impurity 29 |
|
|
|
Benzeneacetonitrile, 4-(4-chloro-1-oxobutyl)-α,α-dimethyl- |
169032-17-1 |
C14H16ClNO |
|
Oseltamivir Impurity 103 |
|
|
|
Oseltamivir Impurity 101 |
|
|
|
Oseltamivir Impurity 90 |
|
|
|
Oseltamivir Impurity 79 |
|
|
|
Oseltamivir Impurity 73 |
|
|
|
Oseltamivir Impurity 69 |
|
|
|
10-メトキシ-6-メチルエルゴリン-8β-メタノール |
35121-60-9 |
C17H22N2O2 |
|
INDEX NAME NOT YET ASSIGNED |
2514957-39-0 |
C16H16FN3O4 |
|
Propanoic acid, 2,2-dimethyl-, 4-[[[2-[[(2-methoxy-2-oxoethyl)amino]carbonyl]phenyl]amino]sulfonyl]phenyl ester |
127373-95-9 |
C21H24N2O7S |
|
Fulvestrant Impurity 1 |
|
|
|
CefazolinH020-02-I-02 |
|
|